Mitochondrial Etiology of Osteoporosis.

被引:0
|
作者
Eliseev, Roman [1 ]
Madukwe, Jerry [1 ]
O'Keefe, Regis [1 ]
机构
[1] Univ Rochester, Rochester, NY 14627 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1122
引用
收藏
页码:S42 / S42
页数:1
相关论文
共 50 条
  • [31] Osteoporosis. Summary and table.
    Peters D.C.
    Coleman S.G.
    Drugs in R & D, 1999, 1 (3) : 203 - 209
  • [32] Osteoprotegerin as a potential therapy for osteoporosis.
    Hamdy N.A.
    Current Osteoporosis Reports, 2005, 3 (4) : 121 - 125
  • [33] PRIMARY HYPERPARATHYROIDISM AND OSTEOPOROSIS. MANAGEMENT
    Athanassiou, P.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S82 - S82
  • [34] Familial risk characteristics of osteoporosis.
    Henderson, LB
    Goldstein, DR
    Braunstein, G
    Adams, J
    Rotter, JI
    Scheuner, MT
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A201 - A201
  • [35] Promising new agents in osteoporosis.
    Reginster J.Y.
    Henrotin Y.
    Gosset C.
    Drugs in R & D, 1999, 1 (3) : 195 - 201
  • [36] Predicting response to etidronate in osteoporosis.
    Crilly, R
    Hodsman, A
    Platt, N
    Cook, C
    Adachi, J
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 664 - 664
  • [37] Implications of expanding the definition of osteoporosis.
    Herndon, MB
    Schwartz, LM
    Woloshin, S
    Welch, HG
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 86 - 86
  • [38] Osteoporosis. Prevention - diagnostics - therapy
    Jaeschke, B.
    GESUNDHEITSWESEN, 2008, 70 (11) : 689 - 689
  • [39] Estrogens and SERMs in the treatment of osteoporosis.
    Ribot, C
    Tremollieres, F
    Pouilles, JM
    ANNALES DE MEDECINE INTERNE, 2000, 151 (06): : 490 - 496
  • [40] Post-transplantation osteoporosis.
    Negri, AL
    Plantalech, LC
    Picasso, MFR
    Otero, A
    Sarli, M
    MEDICINA-BUENOS AIRES, 1999, 59 (06) : 777 - 786